Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology

The Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology is a premier Russian state-owned scientific organization specializing in infectious diseases, immunology, and biotechnology. Founded in 1895, the institute is a pioneer in the development and production of immunobiological preparations, most notably probiotics and cytokine-based therapies. Its product portfolio includes well-known brands such as Kipferon, Bifidumbacterin, and various diagnostic systems for clinical microbiology. Operating under the jurisdiction of Rospotrebnadzor, the institute plays a vital role in national epidemiological surveillance and the advancement of therapeutic strategies for dysbiosis and immune-related disorders. The institute combines fundamental research with large-scale manufacturing, maintaining a significant presence in the Russian pharmaceutical market.